Victory Capital Management Inc. Boosts Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Victory Capital Management Inc. raised its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 14,732.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,798,108 shares of the company's stock after acquiring an additional 6,752,274 shares during the quarter. Victory Capital Management Inc. owned approximately 3.19% of Bath & Body Works worth $206,119,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its position in shares of Bath & Body Works by 38.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after purchasing an additional 11,681 shares in the last quarter. Kovitz Investment Group Partners LLC purchased a new position in shares of Bath & Body Works during the fourth quarter valued at about $258,000. Merit Financial Group LLC purchased a new position in shares of Bath & Body Works during the first quarter valued at about $714,000. Nuveen Asset Management LLC grew its position in shares of Bath & Body Works by 3.7% during the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock valued at $29,628,000 after purchasing an additional 27,136 shares in the last quarter. Finally, New Age Alpha Advisors LLC purchased a new position in shares of Bath & Body Works during the fourth quarter valued at about $1,350,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Performance

NYSE:BBWI traded up $0.08 during trading hours on Friday, reaching $31.79. The company's stock had a trading volume of 4,055,565 shares, compared to its average volume of 5,252,643. The company has a market capitalization of $6.73 billion, a P/E ratio of 8.48, a price-to-earnings-growth ratio of 1.06 and a beta of 1.72. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87. The stock has a 50 day moving average price of $30.16 and a two-hundred day moving average price of $32.30.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business's quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.38 earnings per share. As a group, analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on BBWI shares. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Wells Fargo & Company lifted their price target on Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 14th. Citigroup lifted their price target on Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. UBS Group lifted their price target on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Finally, Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $42.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.